coated tablets,
Sponsors
International Bio Service Co., Ltd., Bio-innova and Synchron.Co.,Ltd, Abbott Healthcare Products B.V., International Bio Service Co.,Ltd.
Conditions
Bioequivalence Study,Bioequivalence study
Bioequivalence
EtoricoxibHealthy volunteers
Healthy volunteers
Bioequivalence
Etoricoxib
Pharmacokinetic studySildenafil concentration in plasma
Sildenafil citrate tablet
Bioequivalence
Phase 1
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Etoricoxib film-coated tablets, 120 mg relative to Arcoxia® 120 mg tablets in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20181002006
Start: 2019-01-07Target: 24Updated: 2026-03-30
A Randomized, Single-Dose, Two-way Crossover, Open-label Study to Evaluate the Pharmacokinetics of Etoricoxib Tablet 120 mg and Arcoxia(R) 120 mg in Healthy Thai Subjects under Fasting Conditions
Active, not recruitingTCTR20190428001
Start: 2019-07-05Updated: 2026-03-30
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Olmesartan Medoxomil 40 mg Film-coated Tablets and Reference Product (OLMETEC) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20200916004
Start: 2020-11-16Target: 28Updated: 2026-03-30
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Febuxostat 80 mg Film-coated Tablets and Reference Product (Feburic® 80 mg) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20201126003
Start: 2021-02-01Target: 42Updated: 2026-03-30
Open-label, Randomized, Two-way Crossover, Two-sequence, Two-period, Two-treatment Bioequivalence Study of Apixaban Tablets 5 mg in Healthy Thai Volunteers
Active, not recruitingTCTR20201216004
Start: 2021-03-01Target: 36Updated: 2026-03-30